Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Recruiting 2Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Other 1

Conditions

Breast Neoplasms 58Neoplasms 51Colorectal Neoplasms 32Prostatic Neoplasms 29Carcinoma, Non-Small-Cell Lung 25Lung Neoplasms 23Leukemia, Myeloid, Acute 20Recurrence 12Multiple Myeloma 12Head and Neck Neoplasms 12Stomach Neoplasms 11Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Neoplasm Metastasis 11Melanoma 11Squamous Cell Carcinoma of Head and Neck 10Lymphoma, Non-Hodgkin 10Carcinoma, Hepatocellular 10Ovarian Neoplasms 9Brain Neoplasms 9Uterine Cervical Neoplasms 8Pancreatic Neoplasms 8Myelodysplastic Syndromes 8Motor Activity 8Lymphoma 8Glioma 8Esophageal Neoplasms 8Carcinoma, Renal Cell 8Leukemia 7Glioblastoma 7Polycystic Ovary Syndrome 6

Interventions

naldemedine 1Olanzapine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × Nausea × 30 days × Clear all
NCT07038551 2026-06-03

Prophylactic Use of Naldemedine on Opioid-induced Nausea and Vomiting in Patients With Cancer: POSEIDON Study

International University of Health and Welfare

Phase 4 Completed
120 enrolled
Other

Constipation, Nausea, Vomiting

NCT07403370 2026-05-19

Olanzapine Dose Comparison for the Prevention of HER-INV: A Network Meta-Analysis

Shandong Cancer Hospital and Institute

Completed
2,000 enrolled

Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡